BWX Technologies Unveils First-Ever 2030 Targets, Flags $3.5 Billion in Uncommitted Capital for M&A as Nuclear Backlog Doubles to $8.4 Billion
Investor Day held September 29, 2026 at the New York Stock Exchange
BWX Technologies used its first investor day in nearly three years to lay out, for the first time, explicit 2030 financial targets rather than the directional medium-term ranges it has given previously, while disclosing that it will have roughly $5.5 billion of capital to deploy through the end of the decade — including $3.5 billion of discretionary firepower after covering capex, dividends and buybacks. The Lynchburg, Virginia-based nuclear component and fuel maker also confirmed that its backlog has more than doubled to $8.4 billion from $4 billion when it last held an investor day in February 2024, a level management says represents nine quarters of revenue and underwrites the bulk of the new growth targets.
2030 Targets Mark a Step-Change From Prior Guidance
CFO Michael Fitzgerald told investors the company is targeting $5.5 billion to $6 billion of revenue by 2030, up from $3.8 billion expected this year, alongside adjusted EBITDA of $1.1 billion to $1.2 billion and free cash flow of $525 million to $575 million. That implies low-double-digit revenue growth, low-to-mid-teens EBITDA growth, and low-double-digit free cash flow growth annually — materially higher than the mid-single-digit revenue and EBITDA growth rates management had guided to at its last investor day in 2024. BWXT has since blown through those prior targets: it delivered a 15% revenue CAGR (8.5% organic) versus a mid-single-digit target, 12% EBITDA CAGR versus mid-single-digit, and 18% free cash flow CAGR versus a double-digit goal. Fitzgerald was explicit that adjusted EBITDA margins are expected to expand from 17.5% this year to approximately 20% by 2030, a roughly 300-basis-point improvement he characterized as largely within the company's control. "The 20% doesn't assume that mix is going to be more favorable," he said. "We're expecting to earn that improvement through execution, through productivity, through value capture and through scale."
Balance Sheet Gets Investment-Grade Rating, Opens Door to Bigger M&A
Fitch assigned BWXT an investment-grade rating last week, with the company now pursuing similar ratings from other agencies. Combined with a $1.25 billion zero-coupon convertible note issued last November and a renegotiated, expanded credit facility, total liquidity stands at $1.7 billion versus under $300 million a year ago following the Kinectrics acquisition. Chief Strategy Officer Rik Geiersbach said the M&A pipeline is "quite robust" across every business line and that the company is no longer anchored to the smaller tuck-in deals of the past, now evaluating "medium-sized plays as well as some potentially more transformative plays," framed against the company's stated ambition to be a "Global Nuclear Industrial Champion." Fitzgerald was careful to note that M&A is layered on top of, not embedded as a requirement for, the 2030 targets — more than half of the growth is expected from what the company calls its "predictable core" of existing contracts and backlog conversion.
Backlog Conversion Visibility Extends Through 2027
Of the $8.4 billion backlog, nearly $7 billion sits in the Government Operations segment, driven by long-lead Navy shipbuilding contracts. Book-to-bill has remained above 1x for several years and stood at 1.7x on a trailing-twelve-month basis as of the second quarter. Management flagged that $4.5 billion of backlog — up 40% year-over-year — is expected to convert to revenue by the end of 2027, giving unusually strong visibility into next year's results. CEO Rex Geveden emphasized this is contracted, not aspirational: "This is real commitment... not talking about a market forecast or pipeline opportunities."
Enrichment and Special Materials Emerge as a New Multi-Billion-Dollar Franchise
One of the most significant new disclosures centered on the U.S. government's push to rebuild domestic uranium enrichment capacity outside of Russian supply chains. Geveden cited a GAO estimate that reconstituting fully unobligated (U.S.-sourced, tip-to-tail) defense fuel capability — from mining through high-enriched uranium — could represent a $37 billion opportunity, of which BWXT's current $1.5 billion contract to industrialize the Oak Ridge-derived DUECE centrifuge technology is "just the tip of the spear." Geveden said he believes BWXT has "a chance to win a good chunk of that, if not all of it." Government Operations President Joe Miller noted the U.S. currently has 4.8 million SWU of enrichment capacity, none of it government- or U.S. company-owned, against 15 million SWU of commercial demand — a gap the pending Russian uranium import ban makes more acute. Layered on top of this, the special materials segment — which includes the recently awarded $1.63 billion, 2,000-metric-ton high-purity depleted uranium (HPDU) contract with the U.S. government — is expected to grow at a 24% CAGR through 2030. That contract emerged just nine months after BWXT's $100 million acquisition of Aerojet Ordnance Tennessee (AOT) in January 2025, a deal Geveden called highly strategic because it gave the company "the full spectrum of uranium assays."
Commercial Nuclear Build-Out: Bigger Backlog, Bigger Per-Reactor Economics
Commercial Operations President John MacQuarrie quantified for the first time what a new reactor order is worth to BWXT by technology type: $350 million to $700 million in revenue per CANDU reactor, "low hundreds of millions" per AP1000, and $50 million to $100 million per small modular reactor, depending on design (a boiling-water SMR like GE Vernova's BWRX-300 generates less content than a pressurized design like Rolls-Royce's SMR, which includes steam generators). MacQuarrie flagged Canada alone as a CAD 120 billion to CAD 150 billion opportunity for new large reactors over the next two decades, citing Bruce Power's planned Bruce C site and Ontario Power Generation's Wesleyville site, which could eventually host eight reactors and become "one of the world's largest nuclear generating sites." The commercial segment's guidance is aggressive: high-teens revenue CAGR through 2030, EBITDA margins expanding from roughly 13% today to the high teens, and EBITDA CAGR above 20%. MacQuarrie noted the segment's bid pipeline is "unlike anything I've ever seen before" in his three decades in the industry, though Fitzgerald cautioned that the real inflection from new large-reactor and SMR orders likely lands in 2028-2029 rather than 2027, which is guided to high-single-digit organic commercial growth — a tougher comparison after 2026's outsized gains.
Operational Leverage Already Showing Up in Production Rates
Management pointed to concrete throughput gains as evidence that operational excellence initiatives (branded internally as "Driving Performance Excellence") are working ahead of the capital-heavy buildout. MacQuarrie disclosed that BWXT's steam generator production, contractually obligated at one unit per month, is now running above 1.5 units per month — effectively a 50% capacity gain without new square footage. Government Operations margins rose from 19% to 20.5% year-to-date, which Miller attributed to factory optimization across the segment's 3 million square feet, with further upside expected as new greenfield enrichment and HPDU facilities are built with full automation from the outset rather than retrofitted.
Portfolio Reshaping: Medical Exit, PCG Entry, mPower Revival
BWXT is divesting the majority of its medical isotopes business for up to $800 million while retaining a 20% stake, a move Geveden framed as portfolio discipline rather than a lack of confidence in the business: "that medical business, frankly, a couple of rings away from the bull's eye... it is better off in other hands." Proceeds and the resulting focus leave the company purely oriented around national security and commercial nuclear power. Simultaneously, the recently closed Precision Components Group (PCG) acquisition gives BWXT its first U.S. commercial nuclear manufacturing footprint across sites in Pennsylvania and New Jersey, adding roughly 10% to overall manufacturing capacity. In a notable resurrection, BWXT disclosed it has licensed its shelved mPower small modular reactor design — originally developed from 2007 to 2015 before being mothballed for economic reasons — to two separate companies: Applied Atomics for terrestrial deployment and CORE POWER for a barge-mounted marine power concept. BWXT retains manufacturing rights and will act as the merchant supplier once either program reaches commercialization, a structure Miller said "monetizes all that investment" without requiring BWXT to fund further design and licensing risk.
TRISO Fuel Economics and the Kairos Partnership
Miller pushed back on the notion that TRISO fuel is inherently expensive, arguing cost is a function of volume rather than technology: "Everything is really expensive when you make a little bit of it." He pointed to a partnership with Kairos Power — backed by Google — where Kairos is investing in pebble manufacturing robotics and automation while BWXT contributes two decades of fuel manufacturing know-how, with the explicit goal of driving down unit costs as demand scales. Management declined to give specific per-kilogram cost or revenue targets, saying capacity investment decisions remain tied to firming demand signals and the availability of HALEU feedstock, and that a decision on a new greenfield TRISO facility is not imminent.
Naval Shipbuilding Upside Not Yet in Numbers
The core Naval Nuclear Propulsion business — roughly half of total company revenue — is guided to 4-6% CAGR based on existing Virginia-class, Columbia-class and Ford-class programs. Management was clear that this baseline excludes any contribution from the proposed nuclear-powered "battleship" concept or the trilateral AUKUS submarine program with Australia and the U.K., both of which remain outside the 2030 framework pending further government appropriations and contracting decisions. Fitzgerald noted that pricing per ship set is not disclosed because of the large fixed-cost structure of naval reactor manufacturing, which is established independent of final unit volumes negotiated with the Navy.
On political risk, Chief Corporate Affairs Officer Suzanne Sterner told investors that BWXT's programs enjoy durable bipartisan support regardless of how the midterm elections shake out, noting current generic ballot polling shows Democrats up roughly 8.5 points with the Senate "surprisingly in play." Geveden added that after living through five presidential transitions in his tenure as CEO, "the support for nuclear has endured... it just doesn't move our business around very much."